WBTN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
WBTN is not a good buy right now for an impatient investor. Despite being deeply oversold (RSI_6 ~15.8) and showing some insider buying, the trend/momentum is still deteriorating (MACD histogram negative and expanding), options flow is heavily put-skewed by volume, and the latest news cycle is dominated by shareholder-law-firm investigation headlines. With no Intellectia AI Stock Picker or SwingMax buy signal to override these negatives, the higher-probability move is continued chop-to-down rather than a clean upside reversal—so I would avoid/step aside rather than buy today.
Price/Trend: Closed at ~$12.13 (-3.97%), weak short-term momentum. Momentum: MACD histogram -0.0889 and negatively expanding => bearish momentum still building. RSI: RSI_6 at 15.81 => extremely oversold, so a dead-cat bounce is possible, but oversold alone is not a buy trigger while MACD worsens. Moving averages: converging MAs suggest consolidation risk, but not a confirmed reversal. Levels: Pivot 12.736 (now below pivot = bearish); near-term support S1 12.159 (being tested) then S2 11.803; resistances R1 13.313 and R2 13.669. Pattern-based stats: similar-pattern model implies weak forward returns (next month bias -6.59%).
Intellectia Proprietary Trading Signals
on 2026-02-26 after hours could become a reset catalyst if results/guidance surprise positively.
Latest quarter: 2025/Q3. Revenue grew to $378.0M (+8.66% YoY), but profitability deteriorated: net income fell to -$11.69M (down -159.17% YoY) and EPS to -$0.09 (down -160% YoY). Gross margin dropped to 21.9% (down -16.63% YoY), pointing to worsening unit economics/monetization efficiency. Net: top-line growth is present, but the trend in margins and earnings is negative, which typically limits upside follow-through after oversold bounces.
Recent trend: mixed but leaning cautious. Evercore ISI reiterated Outperform while cutting PT to $20 from $23 after a Q3 miss (ad revenue drop cited). UBS downgraded to Neutral from Buy and cut PT to $13 from $16, citing limited visibility on partnership timing/deal terms/monetization and expecting the stock to remain range-bound until clearer inflection points.
Wall Street pros: strong market position and user engagement narrative; potential upside from media/partner monetization. Wall Street cons: near-term execution/monetization visibility is low; ad revenue volatility; margin/earnings deterioration; expectation of range-bound trading.
Influential/political trading: No recent congress trading data available (no politician activity to cite). Hedge funds: neutral/no major trend reported.
